JP2015527360A5 - - Google Patents

Download PDF

Info

Publication number
JP2015527360A5
JP2015527360A5 JP2015528460A JP2015528460A JP2015527360A5 JP 2015527360 A5 JP2015527360 A5 JP 2015527360A5 JP 2015528460 A JP2015528460 A JP 2015528460A JP 2015528460 A JP2015528460 A JP 2015528460A JP 2015527360 A5 JP2015527360 A5 JP 2015527360A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
trans
item
human
clomiphene citrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015528460A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015527360A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/032659 external-priority patent/WO2014031177A1/en
Publication of JP2015527360A publication Critical patent/JP2015527360A/ja
Publication of JP2015527360A5 publication Critical patent/JP2015527360A5/ja
Withdrawn legal-status Critical Current

Links

JP2015528460A 2012-08-21 2013-03-15 トランス−クロミフェン製剤およびその使用 Withdrawn JP2015527360A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261691722P 2012-08-21 2012-08-21
US61/691,722 2012-08-21
PCT/US2013/032659 WO2014031177A1 (en) 2012-08-21 2013-03-15 Trans-clomiphene formulations and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017167061A Division JP2017206562A (ja) 2012-08-21 2017-08-31 トランス−クロミフェン製剤およびその使用

Publications (2)

Publication Number Publication Date
JP2015527360A JP2015527360A (ja) 2015-09-17
JP2015527360A5 true JP2015527360A5 (enExample) 2016-05-12

Family

ID=48014380

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015528460A Withdrawn JP2015527360A (ja) 2012-08-21 2013-03-15 トランス−クロミフェン製剤およびその使用
JP2017167061A Pending JP2017206562A (ja) 2012-08-21 2017-08-31 トランス−クロミフェン製剤およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017167061A Pending JP2017206562A (ja) 2012-08-21 2017-08-31 トランス−クロミフェン製剤およびその使用

Country Status (22)

Country Link
US (1) US20150202167A1 (enExample)
EP (1) EP2887922A1 (enExample)
JP (2) JP2015527360A (enExample)
KR (1) KR20150041793A (enExample)
CN (1) CN104582686A (enExample)
AU (1) AU2013306393A1 (enExample)
BR (1) BR112015002288A2 (enExample)
CA (1) CA2880388A1 (enExample)
CL (1) CL2015000311A1 (enExample)
CR (1) CR20150096A (enExample)
EA (1) EA201590421A1 (enExample)
HK (1) HK1209636A1 (enExample)
IL (1) IL236911A0 (enExample)
IN (1) IN2015DN01698A (enExample)
MX (1) MX2015001912A (enExample)
NI (1) NI201500022A (enExample)
NZ (1) NZ704679A (enExample)
PH (1) PH12015500331A1 (enExample)
SG (2) SG10201704820SA (enExample)
UA (1) UA113324C2 (enExample)
WO (1) WO2014031177A1 (enExample)
ZA (1) ZA201501124B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA113291C2 (xx) 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
WO2014070523A1 (en) 2012-11-02 2014-05-08 Repros Therapeutics Inc. Trans-clomiphene for use in cancer therapy
EP3015453B1 (en) 2014-10-28 2016-10-12 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of Clomiphene
EP3015454A1 (en) 2014-10-28 2016-05-04 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Stable solid form of trans-Clomiphene citrate
US11737934B2 (en) 2015-10-14 2023-08-29 Qfix Systems, Llc MRI compatible patient trolley
WO2017182097A1 (en) * 2016-04-22 2017-10-26 F.I.S. - Fabbrica Italiana Sintetici S.P.A. Process for the preparation of enclomiphene citrate having needle shaped crystal habit.
CA3098552A1 (en) 2019-11-14 2021-05-14 Apotex Inc. Processes for the preparation of zuclomiphene and intermediates thereof
CA3098725A1 (en) 2019-11-14 2021-05-14 Apotex Inc. Zuclpomiphene salts and crystalline forms thereof
CA3105944A1 (en) 2020-01-22 2021-07-22 Apotex Inc. Crystalline forms of zuclomiphene citrate
EP3907213A1 (en) 2020-05-04 2021-11-10 Pcas Processes for the production of isomerically pure or enriched cis-clomiphene
US11578025B2 (en) 2020-10-19 2023-02-14 Apotex Inc. Processes for the preparation of zuclomiphene intermediates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2914563A (en) 1957-08-06 1959-11-24 Wm S Merrell Co Therapeutic composition
IT951631B (it) 1971-03-18 1973-07-10 Richardson Merrell Spa Composti utili per la separazione di isomeri ottici geometrici e strutturali e relativo procedimen to di sintesi
JP4845165B2 (ja) * 2001-07-09 2011-12-28 リプロス セラピューティクス インコーポレイテッド 男性におけるテストステロン欠損の処置のための方法および物質
CA2561545A1 (en) * 2004-03-31 2005-10-27 Trophogen, Inc. Human glycoprotein hormone superagonists and uses thereof
WO2006019916A1 (en) 2004-07-14 2006-02-23 Repros Therapeutics Inc. Trans-clomiphene for the treatment of benign prostate hypertrophy, prostate cancer, hypogonadism, elevated triglycerides and high cholesterol
EP1991241A4 (en) * 2006-02-23 2009-07-08 Iomedix Sleep Internat Srl COMPOSITIONS AND METHODS FOR INTRODUCING AND MAINTAINING HIGH-QUALITY SLEEPING
WO2009051908A1 (en) 2007-10-16 2009-04-23 Repros Therapeutics Inc. Trans-clomiphene for metabolic syndrome
TWI458478B (zh) * 2008-11-07 2014-11-01 Repros Therapeutics Inc 用於代謝症候群與第2型糖尿病的反式氯米芬

Similar Documents

Publication Publication Date Title
JP2015527360A5 (enExample)
JP2016540021A5 (enExample)
JP2017057230A5 (enExample)
WO2012079092A3 (en) Testosterone undecanoate compositions
JP2015038149A5 (enExample)
RU2012148710A (ru) Органическое соединение для применения при лечении рака печени
JP2013529665A5 (enExample)
JP2018527305A5 (enExample)
MY207496A (en) Sustained-release formulations of colchicine and methods of using same
TN2012000362A1 (en) Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
JP2016515628A5 (enExample)
JP2017506624A5 (enExample)
EA201492010A1 (ru) Применение высокой дозы лахинимода для лечения рассеянного склероза
RU2011152105A (ru) Составы таблеток 3-цианохинолина и их применение
JP2014098048A5 (enExample)
RU2013154355A (ru) Способ лечения мезотелиомы ингибитором рi3к
PH12013500173A1 (en) Oral controlled release pharmaceutical compositions of blonanserin
JP2012526806A (ja) リコピンおよびレスベラトロールの栄養補助食品
JP2014529584A5 (enExample)
JP5564499B2 (ja) 前立腺癌の進行を予防または減退させるのに有効な組成物
JP2016069375A (ja) 前立腺肥大症の治療及び/又は前立腺肥大症による排尿障害の改善におけるバナナ花抽出物の用途
MX2013003523A (es) Composicion farmaceutica de dosis baja.
EP2575456A4 (en) COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS
RU2017112748A (ru) Композиции онапристона пролонгированного действия и способы
JP2017527627A (ja) 喫煙者における非小細胞肺癌の治療のための、カルボプラチンおよびパクリタキセルと併用したベリパリブ